WASHINGTON — Nine drugmakers on Friday unveiled deals with the Trump administration to lower the prices of some of their drugs, marking the administration’s largest such deal to date. The…
For BioMarin CEO Alexander Hardy, the Friday morning purchase of Amicus Therapeutics for $4.8 billion represents a long-awaited major bet — one Wall Street has been waiting for. Hardy, previously…
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your…
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we exclusively write about how…